In This Episode:
Dr. K speaks with Alzheimer’s expert Jason Karlawish, MD, Co-Director of the Penn Memory Center, about the new anti-amyloid Alzheimer’s medications lecanemab (Leqembi) and donanemab (Kisunla). Learn how biomarkers and other new developments have revolutionized the diagnosing of Alzheimer’s disease, and how these newer medications are being used to treat Alzheimer’s.
They cover: [Read more…]
